Introduction
DNA adducts are covalently bound DNA addition products formed by various DNA-damaging agents. DNA adducts act both as biomarkers and as a measurement of the actual damage done to the genome, which can be manifested by affecting transcription, inducing mutations or tumour initiation. Consequently, DNA adducts are of value to investigate exposure, detect sensitive individuals or populations, as well as identifying agents causing DNA damage (1) (2) (3) (4) (5) (6) (7) .
A common method to measure DNA adducts is through DNA hydrolysis, DNA adduct enrichment, 32 P-post-labelling and chromatographic separation (8) (9) (10) . High-performance liquid chromatography (HPLC) with online radioactivity detection of 32 P, 32 P-HPLC (direct injection of the 32 P-labelled mixture into the HPLC with online 32 P-detection), gives both a high sensitivity and good resolution of complex mixtures of DNA adducts, where even very polar fractions, often washed away at the D1 phase on thin-layer chromatography (TLC), can be detected. The limit of detection for DNA adducts is about 10-fold lower for the HPLC as compared to the TLC with autoradiography detection (adducts per 10 9 as compared to 10 10 normal nucleotides at best, but most values are reported at 10 8 ) (10) (11) (12) (13) . The sensitivity and resolution in both methods depend on the purity of the samples analysed, but by adapting the gradient composition as well as the flow rate through the columns, the resolution can be enhanced for the HPLC system (14) (15) (16) .
One limitation with the 32 P-HPLC method is the sample throughput when dealing with large numbers of samples, due to the time required for each analysis and the inability to conduct parallel analyses, unless using several HPLC systems. The 32 P-TLC does not have this problem as several plates can be run at the same time with the number of samples depending largely on the size of the chromatography tank and the amount of radioactivity one can safely use in an experiment. In addition, several TLC plates can be exposed to X-ray film or phosphoimager screens for analysis at the same time. On the other hand, the two-dimensional chromatographic separation can take at most up to 3 days (day 1 overnight, days 3 and 4 on day 2 and day 5 overnight again), which somewhat reduces these advantages in comparison to HPLC analysis. Since both methods, HPLC and TLC, are commonly used for the analysis of DNA adducts formed in vitro as well as in vivo, attempts have been made to evaluate their efficiency (17) , as well as improve them through various modifications, although not with respect to high-throughput analysis (10) (11) (12) (13) .
The aim of this study was to shorten the time of analysis of DNA adducts by using the 32 P-HPLC method and thereby improve the sample throughput and enable applications to larger studies and populations. The compounds chosen for this purpose were previously structurally identified DNA adduct standards derived from 3-nitrobenzanthrone (3-NBA), which this group has worked with on several occasions. Hence, the standards were readily available and their patterns were well established. In addition, in vivo samples, also involving 3-NBA treatment, were used to perform a complete set of analysis ranging from pure standards, in vitro to in vivo. Moreover, 3-NBA gives rise to a distinctive pattern of several DNA adducts that fall within the retention time area where most bulky DNA adducts, even complex mixtures, studied with this postlabelling method can be found. Hence, it is a good model compound.
Materials and methods

Reagents and chemicals
Reagents and enzymes used were purchased from the following sources: RNAse A from bovine pancreas and spleen phosphodiesterase (SPD) (Calbiochem, Darmstadt, Germany), RNAse T1 from Aspergillus oryzae, Micrococcal nuclease (MN) and Protease K (Sigma Chemical, Cleveland, OH, USA), adenosine 5#-c- 32 P triphosphate ( 32 P-ATP) with specific 32 P-activity of 3000 Ci/mmol (Amersham International, Little Chalfont, UK) and polynucleotide kinase (PNK) (USB, Cleveland, OH, USA). All chemicals were of analytical grade.
The DNA adduct standards N-acetyl-3-amino-2-(2#-deoxyguanosin-8-yl)-benzanthrone 3#-phosphate (Std. 1), 9#-(2''-deoxyribofuranosyl)purino6#,1':2,3i-midazo-5,4-p-1,11b-dihydro-N-acetyl-3-aminobenzanthrone 3#-phosphate (Std. 2), 3-amino-2-(2#-deoxyguanosin-8-yl)-benzanthrone 3#-phosphate (Std. 3), Nacetyl-3-amino-2-(2#-deoxyguanosin-N2-yl)-benzanthrone 3#-phosphate (Std. 4), 3-amino-N-(2#-deoxyguanosin-8-yl)-benzanthrone 3#-phosphate (Std. 5), 3-amino-2-(2#-deoxyguanosin-N2-yl)-benzanthrone 3#-phosphate (Std. 6), 3-amino-2-(2#-deoxyadenosin-N6-yl)-benzanthrone 3#-phosphate (Std. 7) and N-acetyl-3-amino-N-(2#-deoxyguanosin-8-yl)-benzanthrone 3#-phosphate (Std. 8) were kindly provided by Takamura-Enya, Department of Applied Chemistry, Kanagawa Institute of Technology, Kanagawa, Japan.
Warning: The substances, 3-NBA, 3-NBA derived metabolites, phenol and 32 P-ATP that are used in the experimental procedures are extremely hazardous and proper precautions and guidelines should be followed when handling and discarding the chemicals.
Sample preparation
Standards were dissolved in MilliQ water to 100 nM concentrations, whereas adducted DNA samples were obtained in vitro (A549 human lung cells treated with 10 lM 3-NBA for 24 h) and in vivo (lung tissue from a female SpragueDawley rat, 300-380 g, intratracheally treated with a single dose of 2 mg 3-NBA/kg body weight and sacrificed after 48 h). In vivo DNA sample was kindly provided by Schmeiser, DKFZ, Heidelberg, Germany.
The isolation, work-up procedures and labelling of the DNA samples are described in detail elsewhere (18, 19) . Briefly, following homogenization and digestion by RNAse A, T1 and Protease K, a phenol:chloroform extraction was performed. DNA was precipitated over night using 5 M NaCl and 95% ethanol and re-dissolved in MilliQ water for determination of concentration. Aliquots were hydrolyzed using an MN/SPD protocol and finally labelled as described below.
32
P-post-labelling A 100 fmol of the standards and 5 lg of in vitro or in vivo DNA samples were used for labelling. The evaporated samples were re-dissolved in 2.5 ll MilliQ water and a mixture of 0.25 ll PNK buffer (400 mM, pH 9.6), 0.5 ll T4-PNK enzyme (10 U/ll) and 1.75 ll 32 P-ATP (10 lCi/ll) was added to a total volume of 5 ll, followed by incubation for 30 min at 37°C. After incubation, the samples were stored at À20°C until analysis. Samples were diluted to 150 ll with MilliQ water prior to injection into the system and were re-analysed in triplicates.
Instrumentation
The HPLC system consisted of a 600E Multisolvent Delivery System (Waters Chromatography Division, Millipore Corporation, Milford, MA, USA). Radioactivity was measured online with a Packard 500 TR flow scintillation detector with a 500-ll cell (Packard Instrument Co., Meriden, CT, USA) and 2 ml/min of scintillation cocktail Flo Scint IV (PerkinElmer Life and Analytical Sciences, Boston, MA, USA). The energy window was set to 8-600 keV with a counting efficiency of 60% for 32 P. Counting was performed in 12-sec cycles. The analytical system used for classical 32 P-HPLC consisted of a Hichrom, RP 5-C18, K-100 guard column (Hichrom Ltd, Reading, UK) and two serial main columns Delta Pakä 5 l, C18-100A, 3.9 mm i.d. Â 150 mm (Waters Chromatography Division, Millipore Corporation), and for the accelerated 32 P-HPLC, a Chromolith Guard Cartridge RP-18e 10 Â 4.6 mm and two serial main columns Chromolith Performance RP-18e, 100 Â 4.6 mm (Merck KGaA, Darmstadt, Germany). In both cases, a switch valve Swagelok 40 series ball valve (Whitey Co., Highland Heights, OH, USA) was used between pre-and main columns to divert flow.
The HiChrom and Delta Pak C18 columns are what can be referred to as a traditional particulate column packed with tiny beads of silica of 5-lm diameter (in our case). The Chromolith columns are instead made from a single piece of high-purity polymeric silica, which looks like a 'sponge' (monolithic) with various pore sizes ranging from 2 lm (macropores) to 13 nm (mesopores). This allows for a high flow through the column, with low backpressure as a result. Both column types used in the study were C18 modified and also end capped, which is a secondary bonding step to cover unreacted silanols on the silica surface to eliminate unpredictable secondary interactions. P-HPLC, the switch valve was used to divert the first 60 sec of elution directly to waste to avoid overloading the detector and lower background. With the accelerated 32 P-HPLC, the switch valve was used to divert the first 30 sec of elution directly to waste. Ammonium formate buffer was prepared by dissolving ammonium formate salt in water to 2 M and adjusting pH with formic acid to the indicated value.
Results
Changing the HPLC column from Waters Delta Pak C18 (5 lm 100A, 150 Â 3.9 mm) to a low backpressure Merck Chromolith column (Performance RP-18e, 100 Â 4.6 mm) enabled an increase in eluent flow from 0.5-2.0 ml/min of solvent A. This allowed a decrease in gradient time, for 0-40% of solvent B, from 70-12 min, which was empirically obtained as shorter time points than 12 min gave unacceptably poor resolution. The overall time for analysis was reduced from 100 to 20 min, which reduced chromatographic resolution to some extent ( Figure 1 ). The peaks were characterized by injecting the standards one by one and then as a mix of the individual components.
The resolution could be enhanced in various parts of the accelerated 32 P-HPLC chromatogram by the use of a 5-or 10-min plateau at different places in the otherwise linear eluent gradient (Figures 1 and 2 ).
The time (T) at which to start holding the isocratic plateau given a certain concentration of solvent B (X) was obtained using the equation Xð%Þ5TðminÞx 40 12 (as the gradient was linear 0-40% from 0 to 12 min). When the retention time of individual signals was plotted against the percentage of solvent B in the gradient plateau, it was discovered that each substance had a certain small concentration range of solvent B where it started to change its retention time very fast (the almost horizontal part of the curves in Figure 3) . By plotting the level of solvent B at the minimum slope (point of inflexion) for each peak curve versus the retention time of the peak at the basic gradient and fitting a trendline to the plot, an equation for the optimal gradient plateau for each part of the chromatogram was established. When the basic gradient was 2.0 ml/min of solvent A with a gradient of 0-40% of solvent B in 12 min, the equation was Xð%Þ52:029xtðminÞ À 4:3298, where 'X' is % of solvent B, and 't' is the retention time of the basic gradient around which maximum resolution is required (Figure 4) . Thus, to obtain the amount of solvent B required for an optimal start, the gradient plateau can be calculated by combining the two equations as follows: To achieve a better separation at t 5 12 min of the original gradient, the plateau therefore has to start at T 5 6 min, which corresponds to 6x With the accelerated method, some of the peaks have changed the order of elution (Table I) , and these three were exclusively non-acetylated dGp adducts. Other standards consisting of either acetylated dGp adducts or dAp adducts have maintained the order by which they are eluted. Since the peaks have been greatly pressed together, this was not possible to distinguish in the mixed standard samples, in vitro ( Figure 5A and B) or in vivo ( Figure 5C and E). The retention time, as compared to previous analysis, has been greatly reduced albeit to the cost of resolution of individual peaks.
Retention time shift in case of consecutive injections of in vitro and in vivo samples was insignificant, generally ,30 s, and were mostly seen when columns were changed (data not shown). The adduct levels detected were slightly lower with the plateau methods compared to the classical method: 14-37% for the 5-min plateau and 23-26% for the 10-min plateau ( Figure 5C-E) . The extent of the labelling was estimated by the level of free phosphates, ATP and normal nucleotides displayed in the beginning of the chromatogram.
Discussion
Previously, the 32 P-HPLC method has been used to improve resolution with respect to the substances analysed (13, 20, 21) . The conventional way of analysing bulky DNA adducts with P-HPLC the 32 P-HPLC system employs a total run time for analysis of 100 min, including a 10-min post-wash of the system since it was designed for bulky and lipophilic substances such as PAHs and nitro-PAHs (11) . To improve the 32 P-HPLC method with respect to more time-efficient analyses and thereby larger amounts of samples, the task to shorten analysis time without losing sensitivity was undertaken.
By changing certain parameters of the chromatographic 32 P-HPLC method, an approximately 5-fold increased throughput of analyses was obtained, increasing the number of samples in an ordinary 5-day working week, from 25 to $120 (Table II) . A relative comparison on a yearly basis would give an increase from ca. 1200 to ca. 5800 analyses, which represents an improvement of capacity of ca. 480%. The resolution between individual bulky DNA adducts was decreased (compare Figure 1A and B), but still were well resolved from other components of DNA, which is important when the total amount of DNA adducts with a swift qualitative analysis is of primary interest as in the case of complex mixtures (22) . Higher resolution could be achieved by gradient modifications, e.g. the gradient plateau method, which has already been used with the 'classical' system, enabling the resolution of at least up to 40 different DNA adducts from one substance and even permitting resolution of many stereo-isomers of the same DNA adduct (13) . This approach leads to an increase in time required per analysis of 10 min, increasing the total time of analysis from 20 to 30 min. This still leaves a .3-fold increase in capacity from ca. 25 to ca. 80 analyses in an ordinary 5-day working week (Table II) .
As shown in Figure 5A and B, in vitro samples of human cells incubated with 3-NBA display a very good separation of peaks in the 5-and 10-min plateau gradient. The in vivo samples of rat lung, usually containing more complex DNA adduct patterns, display less resolved peaks in comparison to the in vitro samples, although even in this case an improvement is seen using the 10-min plateau as compared to the 5-min plateau gradient ( Figure 5C and D) .
An interesting feature that was observed is that the order of the peaks, in which they are eluted from the HPLC system, was changed (Table I ). This observation is solely based on separate injections of individual standards, as resolution in the mixtures was not high enough to see this effect. Thus, it is worth noting that complex mixtures of molecules might act differently when injected together as compared to individually. Nonetheless, similar features have previously been observed at our laboratory when altering the conditions on the analysis system in order to improve resolution for some bulky DNA adducts (data not shown). Interestingly, the DNA adducts in this study affected by this shift are exclusively non-acetylated dGp adducts. Interactions with the column packing, the composition of the eluent, the rate of mixing and concentration of the organic component into the eluent, as well as the flow rate, determine the retention time of the DNA adducts. Changing any or several of these parameters can bring a shift in elution order between DNA adducts. This is important to take into consideration if one attempts to compare samples when using different methods of analyses even if the analysis has been performed by the same HPLC system and column.
The adduct levels were reduced somewhat for the highthroughput methods as compared to the classical 100-min method. One of the reasons for the loss of sensitivity could be due to the retention time shift of certain adducts and the poorer resolution of the fast methods. Some polar DNA adducts are eluted at time points where they border to normal nucleotides, as seen in the classical method. These DNA adducts may very well co-elute with the nucleotides and not be taken into consideration in the accelerated methods since focus is on the bulky adducts that are more prominent. In addition, the fast Fig. 3 . Individual peak retention time of DNA adduct standards from 3-NBA when analysed by the accelerated 32 P-HPLC using two serial-coupled Merck Chromolith Performance columns (RP-18e, 100 Â 4.6 mm) with 2.0 ml/min solvent A with a linear gradient of solvent B, 0-40% in 12 min, extended with a 10-min gradient plateau at X% of 87.5% acetonitrile þ 12.5% water. Fig. 4 . The optimal gradient plateau by the accelerated 32 P-HPLC method, i.e. the acetonitrile level where resolution of a certain peak is at the optimum (turning point of the curves in Figure 3) , plotted versus the retention time of the peaks using two serial-coupled Merck Chromolith Performance columns (RP18e, 100 Â 4.6 mm) at 2.0 ml/min solvent A with a linear gradient of solvent B, 0-40% in 12 min, starting at 0:3xTðminÞ. elution gives less time in the detector and hence these parameters could also be further optimized with regard to type and flow of scintillation fluid, energy window and counting time.
The major rate-limiting step to the 32 P-post-labelling method is not solely the analytical system, which can be improved as presented in this paper. It is the work-up procedure of the tissues or cells, from which DNA needs to be obtained and purified, digested and DNA adduct enriched and finally labelled (17, 19, 23) . These steps involve a series of enzymatic reactions that require a certain amount of time. Chemical hydrolysis of the DNA, as in the case of 8-oxo-dG DNA adducts, is considerably faster, but converts nucleotides into nucleosides, which are unsuitable for 32 P-labelling (20) . In order to reduce the time of phenol:chloroform DNA extraction, Light Phase Lock Gelsä were used for the phase transfer. This, however, resulted in 5-to 10-fold lower amounts of DNA adducts detected (data not shown). Closer examination of the gels themselves was not performed, and thus, it cannot be said with certainty in what way or to what extent the DNA adducts were bound.
Following the established work-up procedures of DNA extraction with phenol:cholorform, enzymatic digestion using MN/SPD along with butanol enrichment or nuclease P1 treatment before labelling, a wide range of DNA adducts can be analysed using this 32 P-HPLC method. To get an increase in separation of these kinds of DNA adducts, parameters such as flow, gradient and isocratic plateau need to be adjusted. Polar DNA adducts, such as 8-oxo-dG, have short retention times and often drown in the background of high levels of normal nucleotides present in the samples. DNA adducts like 8-oxodG often require additional procedures for proper detection and characterization, but in general, post-labelling is not the best suited for the analysis of such DNA adducts since the radiation itself causes auto-oxidation of the DNA (20,24). 
Accelerated 32
In this high-throughput development of the 32 P-HPLC method, reducing the amount of radioactivity used is also of interest. The radioactive background can be reduced by the help of a switch valve, which is kept open for 30 sec to discard the high levels of ATP, phosphates and some normal unmodified nucleotides that are in excess quantity as compared to the DNA adducts. However, the amount of radioactivity used is currently a maximum of 17.5 lCi for in vitro or in vivo DNA samples, but can be as low as 7 lCi per sample when using 4 lg DNA. A pilot interlaboratory collaboration has indicated that under certain circumstances, a reduced amount of radioactivity can in fact increase sensitivity; however, these results were based on a 32 P-TLC study (D. Phillips, personal communication). Whether this is due to selective labelling of DNA adducts and if it holds true even for this accelerated 32 P-HPLC post-labelling analysis is yet to be evaluated. In general, the 32 P-HPLC method has used less 32 P-ATP for analysis when compared to 32 P-TLC. Several studies are being conducted to lower the amount of radioactivity and speed up the post-labelling process within 32 P-TLC as well as 32 P-HPLC. The authors of this paper have conducted 32 P-HPLC modifications, but there are very few studies reporting any modification to enhance resolution or sensitivity in general (13, 16, (25) (26) (27) .
The future perspective to improve the system even more is to automate injection. At present, each injection is manually performed and once radiolabelled, the set of samples are kept frozen. With an autosampler, the capacity for analyses shown in Table II could be multiplied with a factor of three.
In conclusion, the present study showed that the analytical capacity for 32 P-HPLC could be increased 3-to 5-fold depending on resolution requirements but without significant loss of sensitivity. This accelerated method is best suited for fast analysis and for quantification of a bulk of DNA adducts, rather than individual peaks. Although there were minor variations in quantity following consecutive injections, further optimization can cope with this issue. The rate-limiting steps in the methodology involve the biological steps in the work-up procedures that require manual handling and enzymatic processes. These observations suggest that there are many factors to be considered when developing standardized methods of work-up and analysis with good reproducibility. The data are based on 8-h working days, 5 days/week and 240 days/year. If autoinjection were applied (by a low temperature autosampler), the capacity number would be multiplied with a factor of three. The accelerated 32 P-HPLC method represents an increase in capacity of ca. 320 and 480%, respectively, when compared to the classical 32 P-HPLC method.
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